Mohamad Makhzoumi

Insider Reports History

Entity
Individual
Location
2855 Sand Hill Road, Menlo Park, CA
Signature
/s/ Zachary Bambach, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mohamad Makhzoumi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. 10%+ Owner Common Stock 7.69M $146M $19.00 Jun 28, 2021 Indirect
Savara Inc 10%+ Owner Common Stock 24.5M $109M $4.45 Jul 17, 2023 Indirect
Korro Bio, Inc. 10%+ Owner Common Stock 1.09M $61.1M $56.00 Apr 22, 2024 Indirect
NeueHealth, Inc. Director, 10%+ Owner Common Stock 300K $2.18M $7.27 May 12, 2024 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Common Stock 949K $1.92M $2.02 Apr 11, 2022 Indirect
Metacrine, Inc. 10%+ Owner Common Stock 2.56M $1.2M $0.47 Dec 22, 2021 Indirect
Mirum Pharmaceuticals, Inc. 10%+ Owner Common Stock 11.3K $318K $28.04 Jun 13, 2023 Indirect
Robinhood Markets, Inc. Director Class A Common Stock 6.37K $78.3K $12.28 May 2, 2022 Direct
NeueHealth, Inc. Director, 10%+ Owner Restricted Stock Units 10.5K $76.3K $7.27 May 13, 2024 Direct
NeueHealth, Inc. Director, 10%+ Owner Common Stock 5.94K $43.2K $7.27 May 12, 2024 Direct
IonQ, Inc. 10%+ Owner Common Stock 1.65K $21.9K $13.21 Nov 16, 2022 Direct
Arcellx, Inc. 10%+ Owner Common Stock 283 $15.6K $55.27 Dec 20, 2022 Direct
IonQ, Inc. 10%+ Owner Common Stock 1.05K $13.8K $13.21 Nov 16, 2022 Indirect
AVEO PHARMACEUTICALS, INC. 10%+ Owner Common Stock 559 $8.39K $15.00 Oct 19, 2022 Direct
AVEO PHARMACEUTICALS, INC. 10%+ Owner Common Stock 354 $5.31K $15.00 Oct 19, 2022 Indirect
Desktop Metal, Inc. 10%+ Owner Class A Common Stock 1.27K $933 $0.73 Jun 8, 2021 Direct
Desktop Metal, Inc. 10%+ Owner Class A Common Stock 806 $591 $0.73 Jun 8, 2021 Indirect
MBX Biosciences, Inc. 10%+ Owner Common Stock 3.61M Sep 16, 2024 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Pre-Funded Warrants 3M Apr 11, 2022 Indirect
NeueHealth, Inc. Director, 10%+ Owner Warrant (Right to Buy) 557K Oct 1, 2024 Indirect
Akouos, Inc. 10%+ Owner Common Stock 0 $12.50 Nov 30, 2022 Indirect
Arcellx, Inc. 10%+ Owner Common Stock 0 $55.27 Dec 21, 2022 Indirect
Eargo, Inc. 10%+ Owner Common Stock 0 $2.59 May 25, 2021 Direct
Eargo, Inc. 10%+ Owner Common Stock 0 $2.59 May 24, 2021 Indirect
GENOCEA BIOSCIENCES, INC. 10%+ Owner Common Stock 0 $1.25 May 25, 2022 Indirect
MBX Biosciences, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 Sep 16, 2024 Indirect
MBX Biosciences, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Sep 16, 2024 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series A-2 convertible preferred stock 0 Jun 28, 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 $2.00 Jun 28, 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series C convertible preferred Stock 0 Jun 28, 2021 Indirect
Robinhood Markets, Inc. Director Class A Common Stock 0 $12.28 May 3, 2022 Indirect

Insider Reports Filed by Mohamad Makhzoumi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NEUE NeueHealth, Inc. Oct 1, 2024 4 $0 4 Oct 3, 2024 Director, 10%+ Owner
MBX MBX Biosciences, Inc. Sep 16, 2024 5 $8M 4 Sep 17, 2024 10%+ Owner
MBX MBX Biosciences, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 10%+ Owner
NEUE NeueHealth, Inc. May 12, 2024 3 $0 4 May 14, 2024 Director, 10%+ Owner
KRRO Korro Bio, Inc. Apr 22, 2024 1 $1M 4 Apr 24, 2024 10%+ Owner
NEUE NeueHealth, Inc. Apr 8, 2024 4 $0 4 Apr 10, 2024 Director, 10%+ Owner
BHG Bright Health Group Inc. Dec 19, 2023 1 $0 4 Dec 21, 2023 Director, 10%+ Owner
FREQ Korro Bio, Inc. Nov 3, 2023 0 $0 3 Nov 7, 2023 10%+ Owner
BHG Bright Health Group Inc. Oct 31, 2023 1 $0 4 Nov 2, 2023 Director, 10%+ Owner
BHG Bright Health Group Inc. Sep 15, 2023 1 $0 4 Sep 19, 2023 Director, 10%+ Owner
BHG Bright Health Group Inc. Aug 11, 2023 1 $0 4 Aug 15, 2023 Director, 10%+ Owner
SVRA Savara Inc Jul 17, 2023 1 $1M 4 Jul 19, 2023 10%+ Owner
MIRM Mirum Pharmaceuticals, Inc. Jun 13, 2023 5 $0 4 Jun 15, 2023 10%+ Owner
BHG Bright Health Group Inc. May 12, 2023 3 $0 4 May 16, 2023 Director, 10%+ Owner
ACLX Arcellx, Inc. Dec 20, 2022 6 -$5.5K 4 Dec 22, 2022 10%+ Owner
AKUS Akouos, Inc. Nov 30, 2022 1 $0 4 Dec 2, 2022 10%+ Owner
IONQ IonQ, Inc. Nov 16, 2022 5 $0 4 Nov 18, 2022 10%+ Owner
AVEO AVEO PHARMACEUTICALS, INC. Oct 19, 2022 7 $0 4 Oct 21, 2022 10%+ Owner
BHG Bright Health Group Inc. Oct 17, 2022 2 $138M 4 Oct 19, 2022 Director, 10%+ Owner
GNCA GENOCEA BIOSCIENCES, INC. May 24, 2022 2 -$751K 4 May 26, 2022 10%+ Owner
BHG Bright Health Group Inc. May 13, 2022 1 $0 4 May 17, 2022 Director, 10%+ Owner
HOOD Robinhood Markets, Inc. May 2, 2022 9 -$19.6K 4 May 4, 2022 Director
TRVI Trevi Therapeutics, Inc. Apr 11, 2022 3 $12.5M 4 Apr 13, 2022 10%+ Owner
HOOD Robinhood Markets, Inc. Jan 28, 2022 9 -$29.6K 4 Feb 1, 2022 Director
BHG Bright Health Group Inc. Jan 3, 2022 2 $200M 4 Jan 5, 2022 Director, 10%+ Owner
MTCR Metacrine, Inc. Dec 10, 2021 3 -$494K 4 Dec 27, 2021 10%+ Owner
HOOD Robinhood Markets, Inc. Nov 10, 2021 4 $0 4 Nov 12, 2021 Director
HOOD Robinhood Markets, Inc. Oct 27, 2021 4 $0 4 Oct 29, 2021 Director, 10%+ Owner
TRVI Trevi Therapeutics, Inc. Oct 18, 2021 3 $0 4 Oct 19, 2021 10%+ Owner
HOOD Robinhood Markets, Inc. Aug 2, 2021 20 $77.1M 4 Aug 3, 2021 Director, 10%+ Owner
HOOD Robinhood Markets, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director, 10%+ Owner
BHG Bright Health Group Inc. Jun 28, 2021 22 $35M 4 Jun 30, 2021 Director, 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 28, 2021 7 $20M 4 Jun 30, 2021 10%+ Owner
BHG Bright Health Group Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 Director, 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 10%+ Owner
DM Desktop Metal, Inc. Jun 8, 2021 5 $0 4 Jun 10, 2021 10%+ Owner
EAR Eargo, Inc. May 24, 2021 5 -$9.17K 4 May 26, 2021 10%+ Owner